Agios Pharmaceuticals, Inc. · NASDAQ:AGIO

Morgan Stanley reported a 5.70% stake in Agios Pharmaceuticals, Inc. (Schedule 13G)

Event Sep 30, 2026 · Filed Nov 13, 2026

Morgan Stanley reported a 5.70% stake in Agios Pharmaceuticals, Inc., 3,431,830 shares, as a passive investor on Sep 30, 2026. Filed Nov 13, 2026 (Schedule 13G).

Stake
5.70%
Shares
3,431,830
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Morgan Stanley5.70%3,431,830

Source

Download original · View original at SEC

Related